Possible Treatment for Parkinson's.
Changing the World.
October 31, 2022 1-3pm
Zhyttia is developing a drug, fibroblast growth factor 1 (FGF-1), to possibly treat Parkinson's disease by growing new blood vessels in the brains of individuals suffering from Parkinson's. Besides success in treating monkey's suffering from Parkinson's, Zhyttia is conducting studies on the possibility of treating humans using FGF-1.
Is Angiogenesis a Treatment or Possible Cure?
US FDA Phase IIA Clinical Trial Data
In earlier studies, FGF-1 was utilized to grow new blood vessels in the hearts of individuals suffering from coronary artery disease. This US FDA Phase IIA clinical trial demonstrated the efficacy of FGF-1 in growing blood vessels in ischemic areas of the heart.
improvement in motor skills of Parkinson's patients after treated with FGF-1.
Zhittya conducted additional studies in Parkinson's in August 2022 and is looking to conduct future studies to determine if FGF-1 can improve symptoms of Parkinson's disease as it did for monkeys.
Join the Conversation
Luncheon: Parkinson’s Disease and other Brain Disorders, is FGF-1 a Breakthrough Treatment?
Oct 31, 2022
RSVP for Free
Advanced Revascularization Technology
Vascular ART's mission is to provide continuing education in vascular endovascular surgery field , as well as other physicians and scientists with an active personal involvement and interest in Vascular and Endovascular Intervention . we also aim for exchange of ideas and and updates in our daily practice field , continuous medical education on recently updated studies and guidelines in vascular surgery . our goal is to improve technical and hand skills oof future vascular surgeons and to enhance patient care.
Zhittya is cohosting a luncheon with Vascular ART on October 31, 2022 at 1:00 PM. We invite everyone to register for this luncheon to get access to the latest cutting edge data on Parkinson's disease and its vascular correlation.
Adding Life to Years.